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Objective: To evaluate the usefulness of clinical signs, blood tests, microbiological
cultures and cerebrospinal ﬂuid (CSF) analysis to detect ventriculostomy related in-
fections (VRI), and to describe related conditions.
Methods: A retrospective study was carried out including all patients with external
ventricular drain admitted to intensive care unit from January 2000 to December 2006.
Diagnosis of VRI, mortality, demographic and clinical data, time and number of drains,
microbiological and biochemical CSF results and blood test were recorded. Difference
between infected and uninfected patients was statistically signiﬁcant at P < 0.05.
Results: The results revealed 136 drainages in 120 patients with 22 (18.33%) infected
(15.39 infections per 1000 days of drainage). This group was on overage older, had more
severe systemic response syndrome and a signiﬁcantly higher number of drains and
longer duration of drain insertion. We found statistical differences in proteinorrachia,
glycorrhachia, and glycorrachia/glycemia ratio during 8.5-day drain insertion (inter-
quartile range 7–10.25). A total of 31 cultures were positive in patients without VRI and
47 were negative in patients with VRI. Furthermore, 35 patients died (2 belonging to the
infected group). Signiﬁcantly higher risk of VRI in intraventricular ﬁbrinolysis and
subarachnoid haemorrhage was observed. We made a multivariate regression model
resulting in a prediction rule with 55.7% area under curve (95% CI 0.43–0.70).
Conclusions: CSF routine cultures and biochemical studies are not recommended to
diagnose VRI. Clinical signs, external ventricular drain manipulation and a drainage
insertion over a week justify the routine measurement of proteinorraquia, glycorrhachia
and the ratio of glycorrachia/glycemia.1. Introduction
The external ventricular drain (EVD) constitutes a clinical
standard for the continuous monitoring of intracranial pressure
(ICP) and facilitates the drainage of cerebrospinal ﬂuid (CSF).
Indications for an EVD include primary hydrocephalus,
obstructive hydrocephalus secondary to expansive processes or
intracranial haemorrhage, ICP control in patients with
cranioencephalic trauma and prevention of postoperative CSF
ﬁstulas[1,2]. It facilitates the treatment using intraventricularﬁbrinolysis (IVF) and the administration of local antibiotics
[1,3]. Its indications are limited by the risk of bleeding during
the insertion procedure and the risk of ventriculostomy-related
infection (VRI)[1–6]. The published indication on the VRI
seems to be conﬂicting since incidence rates vary between 0%
and above 50% depending on the authors[1,2,4–10]. There are
no universal criteria to establish its diagnosis; strategies focus
on clinical monitoring and blood and CSF microbiological and
citobiochemical results[1,2,4,6–14]. The clinical assessment of
the patient and certain test results that suggest infection
(leucocytosis, CSF pleocytosis, hypoglycorrhachia, etc.) lose
their predictive value due to the particular characteristics of
the neurocritical patient[15–17], and they can cause delay in its
detection and early treatment; the lack of rentability of the
cultures and the fact that waiting is needed for their results to
be available are also obstacles to an early diagnosis[18,19].ess article under the CC BY-NC-ND license
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sensitive and speciﬁc for the diagnosis of VRI seems necessary,
and, also, to determine CSF parameters to predict its develop-
ment[12]. The etiological agent most commonly involved is the
coagulase-negative staphylococci[1,2,11–13,18,20], however, the
detected amount of Gram-negatives is increasing. Many fac-
tors that could contribute to the development of VRI have been
identiﬁed (associated craniotomy, systemic infection, depressed
cranial fracture, intraventricular haemorrhage, catheter manipu-
lation, and instillation of local treatments)[1,2,4,11,13,14,21,22],
whereas some others are subjects of continuous debate (use of
prophylactic antibiotics, the number of devices, corticosteroids
administration, lengthy stays in critical care units, placement
site of the catheter, prophylactic replacement of the catheter,
duration of the derivation, etc.)[1,4,14,20–28].
The main objective of this study is to evaluate the usefulness
of CSF and blood clinical, cytobiochemical and microbiological
parameters to detect VRI, and the secondary objective is to
describe possible related conditions to such infection.
2. Materials and methods
2.1. Patients
The setting is a 13 bed intensive care unit (ICU) located in a
tertiary referral hospital, which is reference for an area of
400000 citizens. A retrospective review was conducted on the
patient prospective database of our unit and their clinical history,
and those patients who were admitted between 2000 and 2006
and carried one or more EVD were included. Two of the authors,
working independently from one another, registered the
following variables: demography, main diagnosis, score on
severity scales 24 h after admission [Acute Physiology and
Chronic Health Evaluation II (APACHE)[29], and Simpliﬁed
Acute Physiology II Score (SAPS II)[30]], VRI diagnosis,
EVD duration (number of days from insertion until removal),
number of catheters per patient, intraventricular haemorrhage
(IVH) stratiﬁed using the Graeb scale[31], treatment with IVF
and administration of systemic antibiotherapy prior of after
treatment. The presence of systemic inﬂammatory response
syndrome (SIRS)[32], at the same time of VRI and mortality
while in ICU were also registered.
2.2. Insertion technique and care of EVD
While this study was conducted, the clinical guidelines for
the management of EVDs did not suffer any signiﬁcant
alterations.
For insertion, a Lundberg technique modiﬁed by the neuro-
surgery staff was used in theatre or in the ICU, under asepsis and
sterile conditions. Always according to availability and the pref-
erences of the neurosurgeon in charge of the procedure, either
silicon tunnelled ventricular catheters (Becker® PS Medical® by
Medtronic Neurosurgery; Minneapolis, MN, USA) or clindamy-
cin or rifampicin covered catheters (Codman Bactiseal®; Rayn-
ham, USA) were used. Ventricular drainage systems (LCR EDS 3
external drainage system; Codman®, Switzerland) and trans-
ducers for the monitoring of intracranial pressure were also used
(CAMINO® laboratories; NeuroCare San Diego, USA).
For IVF, those patients with a Graeb score above 5 for IVH
were given 10000 intraventricular units of urokinase, for alength of time determined by clinical and tomographic criteria (a
decrease in the amount of intraventricular blood along with a
Graeb score below 6)[31].
For nursing care, watertight drainage system was strictly
preserved and only broken to drain and obtain samples of CSF
or for the instillation of local treatments, and strict asepsis
measures were kept at all times.
For catheter removal, the time of EVD treatment was deter-
mined by the clinical evolution of the patient and the need of
CSF drainage or ICP monitoring. If malfunction or accident
occurs when removing catheter, but the catheter was still needed,
the insertion of a new EVD on an alternative location was car-
ried out. VRI did not justify the removal of the EVD when there
was no indication for such removal.
Those patients with mechanical ventilation for a period
longer than 48 h were subjected to selective digestive decon-
tamination with a pool of amphotericin B, polymyxin, genta-
micin and excipients, and a 3-day course of 2 g of intravenous
ceftriaxone every 24 h.
2.3. Microbiological tests and test results
All EVD patients were subjected to a cytobiochemical test
and CSF culture every 24–72 h from the insertion of the catheter
until its ﬁnal removal, accompanied by a simultaneous blood
test. The CSF samples were cultured in a speciﬁc 35 C and 5%
CO2 environment; germs were identiﬁed and the corresponding
antibiogram with standard microbiological tests was carried out.
For collection and statistical analysis purposes, the moment
of catheter insertion was deﬁned as Day 0. The microbiological
and cytobiochemical results were registered (glycorrhachia,
proteinorrhachia, leucocyte count in CSF, blood sugar levels,
leucocytes in blood and erythrocyte in blood and CSF) noting
the drainage day corresponding to each simple. Several patients
needed EVD during many days, then led to collect many sam-
ples; for data analysis purposes, for each one, ﬁve samples were
selected following uniformity criteria. Discrepant data were
corrected using an overall review of the computerised clinical
history.
2.4. VRI deﬁnition and exclusion criteria
The VRI diagnosis was documented in the medical history of
the patient, and the criteria for its diagnosis was established as
follows: a known pathogen on CSF cultures with the association
of at least two SIRS criteria[32], or, cytobiochemical suspicion[1]
(less than 45 mg/dL hypoglycorrhachia and neutrophilic
pleocytosis higher than 100 per mL) and SIRS symptoms with
a negative culture[32]. The speciﬁcity of the positive cultures
and the SIRS symptoms were subjected to the judgement of
the doctor in charge of the patient who could interpret the
symptoms as EVD colonization or contamination of the
culture (in absence of symptomatology) or as symptoms
related to another condition (pneumonia, urinary tract
infection, etc.).
2.5. Data analysis
SPSS 11.0 (SPSS Ic. Chicago, Illinois) was used. Qualitative
variables were expressed as frequencies and continuous vari-
ables were expressed as mean ± SD and median and interquartile
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Chi-square, student's t-test and Mann-Whitney U test were used
to compare variables of VRI patients and non-VRI patients ac-
cording to statistical criteria. A value of P < 0.05 was considered
statistically signiﬁcant. A multivariate logistic regression anal-
ysis was carried out using the backward Wald iterative method
where the dichotomous dependent and categorical variable was
the VRI diagnosis and the independent variables were age,
drainage length in days, number of EVD, catheter indication,
third CSF sample indication, proteinorrhachia, glycorrhachia
and the glycorrhachia/blood sugar level quotient. Out of them,
the continuous variables were dichotomised using the median as
cut-off point: 60 years old, stay at ICU for 13 days, proteinor-
rhachia of 120 mg/dL, glycorrhachia of 80 mg/dL, and glyco-
rrhachia/blood sugar level quotient of 0.5. The data analysis
program detected automatically those variables which must be
eliminated from consecutive interactions and ﬁnally selected the
indication for EVD (subarachnoid haemorrhage, obstructive
hydrocephalus, IVH and ICP monitoring) and low glyco-
rrhachia/blood sugar levels. The area under the curve for the




Table 1 summarizes the sample characteristics. A total of 120
patients with an average age of 56.84 years (SD 15.77) were
treated with 136 EVD between 2000 and 2006. About 62.5% of
those patients were male. The APACHE II[29] average score was
16.70 (SD 7.36) and the SAPS II[30] average score was 39.23
(SD 15.77).
A total of 1364 derivation days in 119 patients were counted
(one of those patients was already carrying a drain when admitted
from another hospital), scoring a median of 11 EVD days (range
1–33 days); 9 of those patients had the EVD for less that 48 h. A
total of 22 patients who suffered VRI were identiﬁed (18.33%),
the infection rate being 15.39 cases per 1000 drainage days. The
percentage of infected inserted catheters was 16.17%.
3.2. Indications for insertion of EVD
Most of the EVD were inserted due to IVH and obstructive
hydrocephalus. Statistical signiﬁcance was proven for the indi-
cation cause and the development of VRI (P = 0.001).Table 1
Characteristics of the study population.
Characteristics 120 Patients
Age [m (SD)] 56.84 (18.75)
Gender (men/women) 75/45
APACHE [m (SD)] 16.7 (7.36)
SAPS [m (SD)] 39.23 (15.77)
Length of EVD (days) [md (P25–P75)] 11 (1–33)
Number of EVD [m (SD)] 1.13 (0.34)
Intraventricular haemorrhage [n (%)] 49 (40.8%)
Obstructive hydrocephalus [n (%)] 46 (38.3%)
Subarachnoid haemorrhage [n (%)] 13 (10.8%)
Brain tumour [n (%)] 7 (5.8%)
Intracranial pressure monitorization [n (%)] 5 (4.2%)
a: Statistical signiﬁcance; m (SD): Medial value (standard deviation); md (P3.3. Risk factors for VRI
Age, derivation length of time and number of drains were
signiﬁcantly higher in VRI patients (P = 0.008, 0.003 and 0.03
respectively). VRI incidence was signiﬁcantly higher in the
group of patients that carried two or more EVD (RR = 2.67, CI
95% 1.09–6.58) (Table 2), had subarachnoid haemorrhage
(SAH) or IVH (RR = 5.20, CI 95% 1.94–13.95 and RR = 1.44,
CI 95% 0.91–2.28 respectively); IVF resulted in 2.33 times risk
increase (CI 95% 1.33–4.20). The administration of antibiotics
(related to the treatment of other issues) prior to the diagnosis
decreased the VRI risk with no statistical signiﬁcance
(RR = 0.79, CI 95% 0.25–2.45).
3.4. IRV diagnosis
3.4.1. Cytobiochemical ﬁndings in CSF and blood
Out of all the CSF checked samples, 359 were selected for
the ﬁnal analysis: 99 belonged to Day 3 of drainage (P25–P75: 2–
5) and were classiﬁed as “ﬁrst sample”. A total of 86 belonged to
drainage Day 6 (P25–P75: 2–30) and were labelled “second
sample”; 74 belonged to Day 8.5 (P25–P75: 7–10.25) and were
classiﬁed as “third sample”, 58 belong to day 11 (P25–P75: 9.5–
14.25) as “fourth sample”. And ﬁnally 42 were obtained on Day
14 (P25–P75: 12–20.25) and were considered “ﬁfth sample”.
Both VRI and non-VRI groups were very similar on simple
days. In 21 patients no samples were obtained due to shortened
time of drainage or death within the ﬁrst hours of evolution;
none of them had the VRI diagnosis.
A higher proteinorrhachia with signiﬁcantly lower glyco-
rrhachia and glycorrhachia/blood sugar level quotient was found
in those CSF samples that were obtained in EVD Day 9 patients
who had IRV (P = 0.008, 0.03 and 0.0001 respectively). Within
this group, the glycorrhachia was also signiﬁcantly lower on
sample Day 13.
3.4.2. Microbiological ﬁndings
Out of all the CSF samples examined, 296 were selected for a
ﬁnal analysis. Out of them, 69 (23.31%) were positive; out of
those 69, 38 belonged to VRI patients and the rest were labelled
as simple contaminations or catheter colonizations. Out of the
negative samples, 180 belonged to non-VRI patients. On 25
patients no CSF culture was carried out due to a catastrophic
outcome within the ﬁrst hours or to early removal of the catheter;
all of them belonged to the group that did not developed the
infection.22 VRI 98 Non-VRI P
63.59 (10.49) 55.33 (19.87) 0.008a
15/7 60/38 0.540
17.41 (5.57) 16.54 (7.72) 0.910
38.86 (13.21) 39.31 (16.35) 0.620
14 (7–33) 10 (1–31) 0.003a
1.27 (0.45) 1.1 (0.3) 0.030a
12 (54.5%) 37 (37.5%)
3 (13.6%) 43 (43.9%)
7 (31.8%) 6 (6.1%)
0 7 (7.1%)
0 5 (5.1%)
25–P75): Median (interquartile range); n (%): Number of patients (%).
Table 2











49 12 37 1.44 0.91–2.28
Subarachnoid
haemorrhage
13 7 6 5.20 1.94–13.95
Intraventricular
ﬁbrinolysis
32 11 21 2.33 1.33–4.20
Previous antibiotherapy 20 3 17 0.79 0.25–2.45
2 or more EVD 16 6 10 2.67 1.09–6.58
RR: Relative risk.
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microbial infections and three resulted in sterile CSF samples
(Table 3). We found 26 patients with one or more positive CSF
cultures due to EVD contamination or colonization (92.3% were
monomicrobial, and the rest of them were polymicrobial) with
Gram-positive cocci being the predominant organisms.Table 3
Microbiological ﬁndings in VRI.
Microorganism n (%)
CSF culture negative 3 (13.63)
Monomicrobial infections 13 (59.09)
S. epidermidis 5 (22.72)
Pseudomonas sp. 3 (13.63)
S. aureus 2 (9.09)
E. faecalis 2 (9.09)
Stenotrophomonas maltophilia 1 (4.54)
Polymicrobial infections 6 (27.27)
S. epidermidis–S. faecalis 3 (13.63)
S. aureus–E. faecalis 1 (4.54)
S. aureus–S. enteritidis 1 (4.54)
E. agglomerans–E. faecalis 1 (4.54)
S. epidermidis: Staphylococcus epidermidis; S. aureus: Staphylococcus
aureus; E. faecalis: Enterococcus faecalis; S. enteritidis: Salmonella
enteritidis; E. agglomerans: Enterobacter agglomerans.3.4.3. Clinical ﬁndings
SIRS was found in 86.4% of the patients with VRI. No
signiﬁcantly statistical differences were found between the use
of antibiotics for treating an indication prior to the VRI diagnosis
and non-infected patients (13.6% vs. 17.3%, P = 0.673). A total
of 33 patients died, and 31 had no VRI and 2 had (P = 0.032).
3.4.4. Multivariate analysis
A Wald logistic regression model was carried out, using a
measuring ruler that applied to all of them, but calculated on 72
of them, since only they have the information of all the variablesTable 4
Backward Wald iterative method. Prediction rule.
Variables Beta OR
Subarachnoid haemorrhage 1
Obstructive hydrocephalus 3.03 20.88
Intraventricular haemorrhage 1.23 3.42
Intracranial pressure monitorization 22.88 8.69
Low sugCSF/sugBlood quotient 2.06 7.85
Beta: Statistical power; OR: Odds ratio; Low sugCSF/sugBlood quotient: Gincluded in the model. The obtained area under the curve was
55.7% (CI 95%, 0.403–0.709) (Table 4).
4. Discussion
VRI constitutes the most important EVD related complica-
tions, and results in an increase in morbidity and mortality.
Multiple studies have been published describing VRI incidence
and guidelines on how to prevent it. Furthermore, the develop-
ment of standardized protocols and checklists has been thought
to reduce infections through medicine and is used in this same
manner for ventriculostomy placement and its maintenance;
however, most of these studies do not provide a clear deﬁnition
of the diagnostic criteria for this complication[9,13,19,22]. Our
retrospective study on 120 patients who were subjected to an
EVD, analysed the criteria that had to be followed in order to
diagnose VRI (clinical, microbiological and CSF and blood
cytobiochemical). We found that the cytobiochemical changes
for VRI and non-VRI patients are similar during the ﬁrst 8.5
days of admission, and those indications that require a higher
degree of EVD handling (administration of local treatments,
urokinase instillation and repeated sample extraction)[3,7,13], as
well as IVH and SAH seem to increase the risk of developing
VRI. A multivariate analysis was carried out with the purpose
of establishing a VRI risk prediction rule with an under-curve
area of 55.7% (CI 95% 0.439–0.709). Dependent variables
were included in the model which, according to our review and
published data[1,2,4,7,10,20,22], seem to be associated with a
higher VRI incidence: advanced age, presence of two or more
EVD, the use of IVF, the indication for ventriculostomy and
some cytobiochemical results obtained from the CSF sample
taken on EVD Day 8. Although the prediction rule has been
applied to the whole sample, the automatic variable selection
done by the Wald test conditions the fact that it was only
calculated on 72 patients, which resulted in an important loss
on the power of the model and ultimately this could justify the
lack of statistical signiﬁcance.
4.1. Diagnosis, deﬁnition and VRI incidence
Speciﬁc characteristics of the critical patient, some related
complications and neurosurgical and intensive treatments (EVD
insertion amongst them), make the interpretation of the clinical
parameters traditionally used to diagnose meningitis difﬁcult and
alter the CSF composition[11,18,25,33]. Blood presence at
intraventricular level favours the existence of sterile
inﬂammatory events[3,19] known as aseptic or non-infectious
postsurgical meningitis[15–17], which are associated with an
increase of white cell count in CSF samples. These facts have
brought a wide diagnostic controversy, which, with the use of






lycorrhachia/blood sugar level quotient < 0.5.
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rates which can be found in the literature extremely difﬁcult.
Lozier et al.[1], conducted a review on more than thirty VRI-
related articles and suggested that the most referenced VRI
deﬁnition is the one by Mayhall[34], which is based on clinical,
cytobiochemical and microbiological criteria[1,7,11,18,20,22,25,27].
It is very likely that such speciﬁc deﬁnitions involve a loss of
sensibility and assume a smaller VRI incidence, like the one
published by Bota et al. which was 9%[2]. Using strictly
microbiological criteria (one or more positive cultures) groups
can be found which resulted in incidences of 4%[11], 7%[35],
and 16%[18] which have been heavily criticised because of the
variable proﬁtability that cultures have and the possibility that
the sample had been contaminated or the device had been
colonized. Although deﬁnitions are still being discussed
[1,2,9,12,13,22], it is considered that colonization is the presence
of one or more positive CSF cultures with no compatible
symptoms and no cytobiochemical variations. Contamination,
on the other hand, is the isolation of a cutaneous saprophyte
germ that turns negative with no treatment.
Our research contained the criteria that the doctor in charge
of the patient used to diagnose VRI; the incidence resulted in
18.33%, which is similar to the most commonly mentioned
references[1,5,7,14,20,22], in spite of our diagnosis criteria being
more sensitive. Although the majority of our diagnosis is
made on SIRS and CSF positive culture patients, it is worth
to highlight that more than 13% of our EVD patients had
VRI with negative CSF cultures; the VRI diagnosis was
based on cytobiochemical variations and clinical criteria. On
those studies with incidences fewer than 10%[7,11,36–38], the
average age, EVD length of time and the percentage of HIV
and/or IVF were also fewer than the ones in our study.
4.2. Diagnostic utility of CSF analysis:
Cytobiochemistry and cultures and sample extraction
guidelines
In order to diagnose VRI on its early stages, the routine CSF
sampling for analytical purposes has become a regular practice
[1,2,4–6,11,12,15,24–26,37], although its utility has been questioned
in children[11] and adult patients[12]; changes on symptoms or
CSF appearance, or leucocytosis with no evident source make
the CSF sampling advisable[38]. The EVD guidelines that were
being used for the length of time that our data collection
lasted, considered the extraction of samples every 48–72 h
from the moment the EVD was inserted until the time of
removal; we have only found statistically signiﬁcant
differences in some of the parameters checked on EVD Day
8.5; the glycorrachia and glycorrachia/blood sugar level ratio
are signiﬁcantly lower in infected patients, and their
proteinorrhachia is higher. If we consider that VRI is more
frequent in the ﬁrst ﬁve days after EVD insertion, then it is
likely that CSF sampling during the ﬁrst day is only adding
manipulation, thus, increasing the risk of drain infection.
Although some authors have published cutting points for
CSF parameters used to differentiate VRI, the threshold is very
variable: white CSF cell count higher than 11[34], 15[10], 50[18],
100[2] and 7500[17] per microliter, CSF lactate concentration
higher than 4 mg/dL[33], hypoglycorrhachia lower than
10 mg/dL[17] and 40 mg/dL[2], hyperproteinrrhachia above
50 mg/dL[2] and glycorrachia/blood sugar level quotient lower
than 0.5[2,10]. In view of this wide variability, othercytobiochemical markers such as alfa 1 antitrypsin,
haptoglobin, ﬁbronectin and CRP have been evaluated with no
signiﬁcant differences found[3].
Our review did not include these parameters, which are still
being debated. Pfausler et al.[19], suggested cell-index (ratio of
leucocytes to erythrocytes in CSF and leucocytes to erythrocytes
in peripheral blood) as a predictive VRI parameter in HIV pa-
tients, although their methodology[10] has been questioned since
it lacked a truly effective cutting point. In our study, the cell-
index values have been similar when comparing VRI and non-
VRI patient groups; however, we have not tested the cell-
index in HIV patients.
4.3. Microbiological ﬁndings
In our review, microbiological results relate to the published
literature[1,2,7,11,15,18,20,25,26,28,38,39], S. epidermidis and E.
faecalis monomicrobial VRI are predominant and so are the
colonisations and contaminations produced by the same germs.
The fact that we obtained a high percentage of E. faecalis-
related colonisations is favoured by the microbial selection
associated to the digestive decontamination protocol applied in
the unit to those patients on prolonged mechanical ventilation.
Twenty-six patients with no VRI and one or more positive
CSF cultures were identiﬁed. Half of these patients had an EVD
in the context of a IVH (eight of them received intraventricular
ﬁbrinolysis treatment). The data suggest, as published in other
series[1,7–9,14,22], that the repetitive manipulation of the EVD
that is required when IVF is carried out could be a risk factor
for the colonization of the drainage itself or the samples
obtained from it.
4.4. Clinical signs of VRI
Phlogosis at the insertion point[23], headache and nuchal
rigidity[6] are not easy to assess in neurocritical patients. High
temperature has been pointed out as the fundamental clinical
sign that indicates VRI, with values above 38 C or 38.5 C
[11,34], although some authors reject it when diagnosing VRI
[18]. Martinez et al. used the decreased level of consciousness
and a temperature threshold of 37.5 C as part of their
diagnostic criteria[10]. In our clinical study the presence of
SIRS[32] was considered as a clinical sign of VRI; in spite of
being non-speciﬁc, it allows a high sensitivity infectious
screening and it was present in 86% of the infected patients.
The mortality described in the studied simples in this study
(9.1% of the VRI patients) is not fully comparable to the pub-
lished data due to the sample heterogeneity and the lack of
severity indicators described in the literature. The mortality in
the non-VRI sample group was three times higher than that in
the VRI group; this phenomenon could be explained by the
conditions that the drainage time of these patients was shorter
and, hence, a lower VRI risk developed.4.5. Risk factors
The favourable factors for VRI have been highly questioned.
Our team detected a statistically increased risk of developing
VRI linked to indications such as IVF and SAH which required
a higher manipulation (instillation treatment, prolonged sam-
pling) or longer drainage time[7,22]; those indications seem to be
Sergio Castaño A´vila et al./Journal of Acute Disease 2016; 5(2): 143–149148in accordance to published data[4,34]. In those patients presenting
IVH, the risk increase did not reach statistical signiﬁcance, a fact
that was probably related to our restricted sample. We found that
those patients older and with longer EVD time developed VRI
more frequently; this is also a fact that has been observed in
other samples[4,5,14,22,24].
Some EVD guidelines recommend the use of prophylactic
antibiotics around the drain insertion timeframe, which is a
practice that is considered controversial by other researchers[28].
In our study, the antibiotherapy prior to the diagnosis of VRI
meant a certain degree of protective effect with no statistical
signiﬁcance. Although some authors suggest that antibiotic-
impregnated drains reduce the incidence of VRI[40,41], more
well-designed clinical trials are needed in order to evaluate
their effect[26].
The retrospective nature of this study can restrict the validity
of our results. Given the characteristics of its design, the exact
diagnosis moment could not be documented, and the collection
of some relevant factors that allow the development of infection
such as inmunosupresor or steroid treatment or the existence of
intercurrent infections that could interfere with the sample
prognosis was not possible.
Our study did not evaluate whether craniotomies, closed
cranio-encephalic traumas, depressed cranial fractures, coin-
fections, routine drain changes or EVD insertion sites increase
the risk of VRI or not.
VRI diagnosis is based on clinical and microbiological data.
Routine CSF culture and cytobiochemical sampling for the
diagnosis of VRI are not advised; compatible clinical signs,
repetitive device manipulation and/or drainage time longer than
a week can be interpreted as indications for CSF culture and
study of proteinorraquia, glucorraquia and glucorraquia/blood
sugar level quotient.
Those indications that mean a longer insertion and
manipulation time (such as IVF, SAH and IVH) are especially
prone to favour drain contamination, colonization and infec-
tion. More studies that help establish CSF parameters, which,
along with clinical data, allow the prediction of the risk of
developing or existence of meningitis in EVD patients are
needed.
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